Emily’s Entourage Grants $220k to Queen’s University Belfast to advance OmniSpirant’s Gene Therapy for Cystic Fibrosis

PRESS RELEASE We are excited to progress the development of OS001 for CF in collaboration with Prof Lorraine Martin and Dr Lisa Douglas in Queen's University Belfast. Funding support from Emily's Entourage in the USA [...]

January 20th, 2023|

OmniSpirant Limited Announces the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer.

PRESS RELEASE OmniSpirant Limited are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in [...]

December 14th, 2022|

OmniSpirant Named in the World’s Top 5 Startups Developing Drugs for Respiratory Disease

StartUs insights analysis of the global respiratory drug development landscape highlights OmniSpirant's inhaled regenerative gene therapy platform: Omnispirant explores Inhaled Gene Therapy In the last decade, advances in gene sequencing and gene editing have made [...]

March 11th, 2021|
Go to Top